ROBERT FRIEDMAN
Medical Practice in Tavistock, NJ
License number
Pennsylvania MD028295E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Tavistock, NJ 08033
Pennsylvania
Pennsylvania
Personal information
See more information about ROBERT FRIEDMAN at radaris.comName
Address
Phone
4 Woodland Ct, Princeton Jct, NJ 08550
4 Toronto Woods Rd, Manalapan, NJ 07726
449 Saw Mill Ln, Horsham, PA 19044
44 Appleman Rd, Somerset, NJ 08873
431 Wooded Way, Newtown Sq, PA 19073
Organization information
See more information about ROBERT FRIEDMAN at bizstanding.comRobert Friedman MD
48 Colonial Rdg Dr, Tavistock, NJ 08033
Status:
Inactive
Industry:
Medical Doctor's Office
Professional information
Composition For Treatment Of Pain Specification
US Patent:
2008009, Apr 24, 2008
Filed:
Dec 22, 2005
Appl. No.:
11/794058
Inventors:
Robert Friedman - Haddonfield NJ, US
International Classification:
A61K 31/135, A61K 31/195, A61K 31/50, A61K 31/55, A61K 31/497, A61K 31/40, A61K 31/44, A61K 31/20, A61P 19/00, A61P 25/00
US Classification:
514220000, 514561000, 514646000, 514654000, 514249000, 514254060, 514423000, 514282000, 514560000
Abstract:
A method for the treatment of pain and/or inflammation in a subject by the administration of N-acetyl-cysteine (NAC) or derivative thereof and a pain and/or anti-inflammatory medication. The pain or anti-inflammatory medication is metabolized by the action of the cytochrome p450 system. The pain medication includes N-methyl-D-aspartate (NMDA) receptor antagonist(s). NAC and the pain medicine can be administered concurrently or sequentially. The joint administration can result in the use of lower dosages than typical dosage of the pain and/or anti-inflammatory medication or in enhanced relief from the treated condition.
Ketamine Treatment Of Restless Legs Syndrome
US Patent:
6855735, Feb 15, 2005
Filed:
Mar 20, 2002
Appl. No.:
10/102374
Inventors:
Robert Friedman - Haddonfield NJ, US
Assignee:
Temple University of the Commonwealth System of Higher Education - Philadelphia PA
International Classification:
A61K009/00, A61K009/48, A61K009/20, A61K031/135, A61K031/33
US Classification:
514647, 424400, 424451, 424464, 424 7802, 514183, 514289, 514450
Abstract:
The present invention is directed to a method for treating symptoms associated with Restless Legs Syndrome (RLS). The method includes administering to a warm-blooded animal in need of such treatment a dose of ketamine sufficient to alleviate symptoms associated with RLS.